Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Disruption of the ASTN2/TRIM32 locus at 9q33.1 is a risk factor in males for autism spectrum disorders, ADHD and other neurodevelopmental phenotypes.

Lionel AC, Tammimies K, Vaags AK, Rosenfeld JA, Ahn JW, Merico D, Noor A, Runke CK, Pillalamarri VK, Carter MT, Gazzellone MJ, Thiruvahindrapuram B, Fagerberg C, Laulund LW, Pellecchia G, Lamoureux S, Deshpande C, Clayton-Smith J, White AC, Leather S, Trounce J, Melanie Bedford H, Hatchwell E, Eis PS, Yuen RK, Walker S, Uddin M, Geraghty MT, Nikkel SM, Tomiak EM, Fernandez BA, Soreni N, Crosbie J, Arnold PD, Schachar RJ, Roberts W, Paterson AD, So J, Szatmari P, Chrysler C, Woodbury-Smith M, Brian Lowry R, Zwaigenbaum L, Mandyam D, Wei J, Macdonald JR, Howe JL, Nalpathamkalam T, Wang Z, Tolson D, Cobb DS, Wilks TM, Sorensen MJ, Bader PI, An Y, Wu BL, Musumeci SA, Romano C, Postorivo D, Nardone AM, Monica MD, Scarano G, Zoccante L, Novara F, Zuffardi O, Ciccone R, Antona V, Carella M, Zelante L, Cavalli P, Poggiani C, Cavallari U, Argiropoulos B, Chernos J, Brasch-Andersen C, Speevak M, Fichera M, Ogilvie CM, Shen Y, Hodge JC, Talkowski ME, Stavropoulos DJ, Marshall CR, Scherer SW.

Hum Mol Genet. 2014 May 15;23(10):2752-68. doi: 10.1093/hmg/ddt669. Epub 2013 Dec 30.

2.

Chemotherapy dose--response relationships in non-small cell lung cancer and implied resistance mechanisms.

Stewart DJ, Chiritescu G, Dahrouge S, Banerjee S, Tomiak EM.

Cancer Treat Rev. 2007 Apr;33(2):101-37. Epub 2007 Feb 5. Review.

PMID:
17276603
3.

Clinical characteristics and the impact of surgery and chemotherapy on survival of patients with advanced and metastatic bronchioloalveolar carcinoma: a retrospective study.

Donker R, Stewart DJ, Dahrouge S, Evans WK, Shamji FM, Maziak DE, Tomiak EM.

Clin Lung Cancer. 2000 Feb;1(3):211-5; discussion 216.

PMID:
14733647
4.

A phase III study of high-dose intensification without hematopoietic progenitor cells support for patients with high-risk primary breast carcinoma.

Yau JC, Gertler SZ, Hanson J, Verma S, Grimard LJ, Malik ST, Aref IM, Cross PW, Tomiak EM, Stewart DJ, St Cyr DA, Huan SD.

Am J Clin Oncol. 2000 Jun;23(3):292-6.

PMID:
10857897
5.

Estimates of the lifetime costs of breast cancer treatment in Canada.

Will BP, Berthelot JM, Le Petit C, Tomiak EM, Verma S, Evans WK.

Eur J Cancer. 2000 Apr;36(6):724-35.

PMID:
10762744
6.

Concurrent use of multiple low dose chemotherapy agents with differing mechanisms of action as a strategy vs passive resistance: A pilot study.

Stewart DJ, Goel R, Gertler SZ, Huan S, Tomiak EM, Yau J, Cripps C, Evans WK.

Int J Oncol. 1999 Oct;15(4):693-9.

PMID:
10493950
7.

Prospective randomized trial of docetaxel versus mitomycin plus vinblastine in patients with metastatic breast cancer progressing despite previous anthracycline-containing chemotherapy. 304 Study Group.

Nabholtz JM, Senn HJ, Bezwoda WR, Melnychuk D, DeschĂȘnes L, Douma J, Vandenberg TA, Rapoport B, Rosso R, Trillet-Lenoir V, Drbal J, Molino A, Nortier JW, Richel DJ, Nagykalnai T, Siedlecki P, Wilking N, Genot JY, Hupperets PS, Pannuti F, Skarlos D, Tomiak EM, Murawsky M, Alakl M, Aapro M, et al.

J Clin Oncol. 1999 May;17(5):1413-24.

PMID:
10334526
8.

Diagnostic and therapeutic approaches for nonmetastatic breast cancer in Canada, and their associated costs.

Will BP, Le Petit C, Berthelot JM, Tomiak EM, Verma S, Evans WK.

Br J Cancer. 1999 Mar;79(9-10):1428-36.

9.

Follow-up practices for patients with early stage breast cancer: a survey of Canadian oncologists.

Tomiak EM, Diverty B, Verma S, Evans WK, Le Petit C, Will P, Berthelot JM.

Cancer Prev Control. 1998 Apr;2(2):63-71.

PMID:
9765766
10.

Paclitaxel plus hydroxyurea as second line therapy for non-small cell lung cancer.

Stewart DJ, Tomiak EM, Goss G, Gertler SZ, Logan D, Huan S, Yau J, Dulude H, Evans WK.

Lung Cancer. 1996 Aug;15(1):115-23.

PMID:
8865129
11.

The role of chemotherapy in invasive thymoma: a review of the literature and considerations for future clinical trials.

Tomiak EM, Evans WK.

Crit Rev Oncol Hematol. 1993 Oct;15(2):113-24. Review. No abstract available.

PMID:
8117414
12.

Routine follow-up of patients following primary therapy for early breast cancer: what is useful?

Tomiak EM, Piccart MJ.

Acta Clin Belg Suppl. 1993;15:38-42. No abstract available.

PMID:
8517092

Supplemental Content

Loading ...
Support Center